
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies is an innovative leader in the developing and manufacturing of silicon nitride biomaterials. Their recent FDA clearance and partnerships with larger companies show promising results for long-term value. While facing competition and slow adoption, their unique technology and potential for use in various medical applications make them an attractive investment with an undervalued current valuation.
Bears say
SINTX Technologies is a platform-driven company with potential for value creation through product sales, partnerships, and new applications. The company's ceramic biomaterials, demonstrated in their FDA-registered manufacturing facility, has the potential to break into the orthopedic markets with differentiated properties within targeted subsegments. However, the company's competitiveness in the orthopedic and medical-device industries may hinder revenue growth in the future. The success of SINTX's product development and commercialization, as well as partnerships with companies like Evonik, will be key factors in driving sustained adoption and revenue growth.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares